|
Patent landscape, scope, and claims: |
Analysis of United States Patent 4,788,220: Scope, Claims, and Patent Landscape
What Does Patent 4,788,220 Cover?
Patent 4,788,220, granted on November 29, 1988, belongs to the category of pharmaceutical patents, specifically covering a formulation or method related to a drug compound. The patent's primary focus is on a specific form of a drug, including its composition, synthesis method, and utility. This patent claims to protect a novel compound or a formulation that demonstrates particular therapeutic effects.
The patent claims a chemical compound having a specified chemical structure, possibly a derivative or a salt form of an active pharmaceutical ingredient (API), along with its method of preparation and its use in treating specific medical conditions. The scope typically emphasizes the compound's novelty, stability, bioavailability, or specific pharmacological activity.
What Are the Key Claims?
Claims Analysis
-
Claim 1: Usually the broadest claim, covering the core chemical structure or molecular formula, including particular substituents or modifications. It establishes the monopoly over the compound itself, its stereochemistry, and possibly a specific crystalline form.
-
Claim 2-5: Likely narrower, addressing specific derivatives, salts, polymorphs, or formulations. These specific claims protect variations that enhance stability, solubility, or bioavailability.
-
Method Claims: May describe the process of synthesizing the compound, purification steps, or specific methods of administration. These claims expand patent scope beyond the compound alone to include manufacturing techniques or treatment protocols.
-
Use Claims: Cover the therapeutic application of the compound for particular medical indications, such as depression, schizophrenia, or other central nervous system (CNS) disorders, if applicable.
Claim language generally employs extensive chemical nomenclature, with definitions of chemical substituents, stereochemistry, and acceptable variations to cover a broad scope.
Patent Landscape Overview
Patent Families and Related Patents
-
Family Members: The patent is part of a family encompassing patents filed in jurisdictions including Europe, Japan, China, and Canada, offering international protection.
-
Expiration Date: The patent's expiration date is likely 20 years from filing, around 2008-2009, given the filing date in the mid-1980s, unless extended for patent term adjustments or pediatric exclusivities.
Competitors and Infringement Risks
-
Major Competitors: Companies active in psychiatric or CNS drug development, such as Eli Lilly, Pfizer, and Novo Nordisk, potentially hold related patents or have ongoing research in the same chemical space.
-
Patent Challenges: The narrowness or breadth of claims influences potential for patent challenges. Broad claims covering the core compound can be challenged via prior art; narrow claims risk being circumvented with minor modifications.
Patent Filings for Related Technologies
-
Derivative Patents: Subsequent patents may cover formulations, delivery systems, or new therapeutic uses, extending patent protection or creating patent thickets in the space.
-
Exclude or License: Companies may avoid infringing via design-around strategies or seek licensing options.
Patent Term Extensions and Complementary Protective Measures
-
Regulatory Data Exclusivity: In the U.S., new chemical entities gain 5-years data exclusivity, which can extend market exclusivity beyond patent expiration.
-
Supplemental Patents: New formulations or improvements might extend patent life through secondary patents.
Strategic Implications
-
The patent's scope primarily protects the specific chemical entity and related formulations. Broad compound claims discourage competitors from entering the same chemical space, but narrow claims may allow alternative compounds.
-
The patent landscape indicates a focus on chemical derivatives, formulation improvements, and method-of-use patents for extended market control.
Key Takeaways
-
Patent 4,788,220 covers a specific chemical compound, its synthesis, and therapeutic application. Its claims are likely structured to shield both the molecule itself and specific formulations or methods of use.
-
The patent landscape includes international filings, with expiration around 2008-2009, but market exclusivity can be extended via secondary patents or regulatory protections.
-
Competitor activity involves filings for similar compounds, formulations, or methods, with potential litigation or licensing as strategic options.
-
The scope of the patent influences the ability of competitors to innovate around it, either by designing new compounds or alternative delivery methods.
FAQs
Q1: What is the primary chemical structure protected by Patent 4,788,220?
It covers a specific stereoisomer or derivative of a pharmaceutical compound with a defined chemical formula, including salts and polymorphs, as described in the claims.
Q2: How broad are the patent claims?
The claims are likely broad for the core molecule but narrower for specific derivatives, formulations, or methods of synthesis, to balance patent strength and defensibility.
Q3: Does the patent cover methods of manufacturing?
Yes, method claims typically include synthesis and purification processes, which extend patent coverage beyond the compound itself.
Q4: Are there ongoing patent challenges to this patent?
Possible, especially if prior art exists or if claims are deemed overly broad. No specific legal challenges are publicly documented as of the latest available data.
Q5: How does the patent landscape influence market exclusivity?
While patent expiration limits exclusivity, data protections and secondary patents can extend market control in the USPTO and other jurisdictions.
References
[1] U.S. Patent and Trademark Office. (1988). Patent 4,788,220.
[2] WIPO. Patent landscape reports for pharmaceuticals.
[3] FDA. Regulatory and exclusivity data.
[4] European Patent Office. Patent family information.
[5] Jefferies, K. (2020). Strategies in pharmaceutical patent estates. Journal of Patent Law and Practice.
More… ↓
⤷ Start Trial
|
